Back to dashboard
All PlansCoverageMedium impact

Magnetic Resonance-Guided Focused Ultrasound

Blue Cross & Blue Shield of Mississippi·MS · Oncology, Neurology, Pain Management +2 more·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

This policy establishes coverage guidelines for Magnetic Resonance-guided Focused Ultrasound (MRgFUS), covering it as medically necessary only for pain palliation in metastatic bone cancer patients who failed radiotherapy and for medicine-refractory essential tremors. Treatment of uterine fibroids, other tumors, and Parkinson's disease tremor remains investigational and not covered.

Action Required

Action needed
Immediately: Billing team must verify prior authorization requirements for MRgFUS procedures and ensure proper medical necessity documentation is obtained before scheduling. Only bill for metastatic bone cancer pain palliation (failed radiotherapy patients) and medicine-refractory essential tremors. Do not submit claims for uterine fibroid treatment, other tumor treatments, or Parkinson's disease tremor as these are considered investigational and will be denied.

Related policy hubs